eClinical Solutions Market by Product, Delivery Mode, Clinical Trial Phases, End User - Global Forecast to 2020 - Research & ...
11 February 2016 - 11:46PM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/zp6fbh/eclinical) has
announced the addition of the "eClinical Solutions Market by
Product, Delivery Mode, Clinical Trial Phases, End User - Global
Forecast to 2020" report to their offering.
The market is expected to reach USD 5.98 Billion by 2020, at
CAGR of 12.1% from 2015 to 2020.
A number of factors such as growing adoption of software
solutions during clinical trials, increasing research and
development expenditure by pharmaceutical companies, growing
government grants to support clinical trials, and rising customer
base are propelling the growth of the global market.
However, high implementation cost, dearth of skilled research
professionals, and lack of awareness of clinical data sciences
software in research community are some of the major factors
restraining the growth of this market. In addition to this,
challenges associated with this market such as low adoption rate in
certain geographies and software reliability and patient privacy
issues related with eClinical solutions are also limiting the
demand for these solutions.
On the basis of geography, this market is classified into four
regions, namely, North America, Europe, Asia-Pacific, and the Rest
of the World. In 2015, the global eClinical solutions market is
estimated to be dominated by North America. A number of factors
such as increasing government grants to support clinical trials,
continuous product development and new product launches by
eClinical solution vendors, growth in the number of partnerships
for new drug development, and high prevalence of lifestyle diseases
with increasing aging population are driving the growth of the
market in the North American region.
The Asia-Pacific market is expected to grow at the highest CAGR
from 2015 to 2020. This is primarily due to the increasing
outsourcing of clinical trials by big pharmaceutical and
biopharmaceutical organizations to developing Asian countries,
growth in government funding to support clinical research, presence
of less stringent regulatory guidelines compared to developed
nations to conduct clinical trials, presence of a large patient
base, and faster patient recruitment for clinical trials in this
region.
Scope of the Report
By Product
- Electronic Data Capture (EDC) and Clinical Data Management
Systems (CDMS)
- Clinical Trial Management Systems (CTMS)
- Clinical Analytics Platform
- Randomization and Trial Supply Management (RTMS)
- Clinical Data Integration Platform
- Electronic Clinical Outcome Assessment (eCOA)
- Safety Solutions
- Electronic Trail Master Files (eTMF)
- Others (Regulatory Information Management Solutions, Coding
Systems, and Core Laboratory Integration Solutions)
By Delivery Mode
- Web-hosted (On-demand)
- Licensed Enterprise (On-premise)
- Cloud-based (SaaS)
By Clinical Trial Phase
- Phase I
- Phase II
- Phase III
- Phase IV
By End User
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organizations
- Consulting Service Companies
- Medical Device Manufacturers
- Hospitals
- Academic Research Institutions
Companies Mentioned
- Bioclinica, Inc. (A Subsidiary of JLL Partners)
- CRF Health
- Datatrak International, Inc.
- ERT
- Medidata Solutions, Inc.
- Merge Healthcare Incorporated
- Omnicomm Systems, Inc.
- Oracle Corporation
- Parexel International Corporation
- eClinical Solutions, Inc.
For more information visit
http://www.researchandmarkets.com/research/zp6fbh/eclinical
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160211005673/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T. Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Clinical Trials